Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
RD

NASDAQ · RDNT

RadNet, Inc.

Healthcare · Medical - Diagnostics & Research

$73.49

Down-$0.16 (-0.22%)

Updated Nov 1, 2026, 4:05 PM

SID Score

5.2/10

Composite research score

Smart Money

58/100

Neutral

Market cap
6.07B
P/E ratio
-462.56
Dividend yield
0.00%
52-week range
$50.82 – $85.84
Volume
571.7K
Avg. volume
753.34K

Price performance · RDNT

RDNT price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

RDNT closed at $73.49 after 20 trading sessions, up 4.14% for the selected period.

Last close
$73.49
Period change
+4.14%
Period low
$68.21
Period high
$73.65
Daily close
View OHLC price history
RDNT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$73.56$74.39$71.91$73.49571.7K
Oct 29, 2026$74.49$75.05$73.40$73.65472.1K
Oct 28, 2026$73.48$75.02$73.33$73.54633.16K
Oct 27, 2026$70.53$74.56$70.49$73.541.27M
Oct 26, 2026$70.58$71.77$69.76$70.05340.09K
Oct 23, 2026$69.53$71.00$69.43$70.34403.64K
Oct 22, 2026$67.77$70.39$67.60$70.26318.37K
Oct 21, 2026$69.48$70.26$68.055$68.41458.55K
Oct 20, 2026$69.92$71.06$69.03$69.65326.24K
Oct 19, 2026$68.91$70.00$68.25$69.27342K
Oct 16, 2026$70.41$70.49$68.51$68.80385.9K
Oct 15, 2026$70.12$70.82$69.07$70.41461.23K
Oct 14, 2026$70.65$71.90$69.02$69.16477.92K
Oct 13, 2026$70.81$72.15$70.0025$71.51478.05K
Oct 12, 2026$70.88$71.78$70.11$71.49383.36K
Oct 9, 2026$68.41$71.105$68.13$70.91507.44K
Oct 8, 2026$68.16$68.50$66.23$68.21722.26K
Oct 7, 2026$69.57$70.66$68.45$68.61398.63K
Oct 6, 2026$71.27$71.545$69.44$70.28291.72K
Oct 5, 2026$69.87$71.86$69.40$70.57681.37K

Latest RDNT news

The latest Smart Investors Daily articles mentioning RDNT.

Stock researchCompany · Overview

RDNT research

Overview

Company profile and research snapshot.

Company profile

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$88.00
Implied upside
—
Analysts
—
RDNT recent ratings
DateFirmRatingTarget
Aug 28, 2026BarclaysOverweight—
Aug 11, 2026Truist SecuritiesBuy—
May 20, 2026BarclaysOverweight—
Apr 21, 2026BarclaysOverweight—
Jan 9, 2026KeybancOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 17, 2026

What RadNet (RDNT) Earnings Beat Means For Shareholders

RadNet recently reported quarterly revenue of $622.7 million, up 25% year on year, with earnings ahead of analyst estimates and performance that exceeded consensus expectations. The update reinforced how RadNet’s mix of imaging centers and digital health services is benefiting from steady diagnostic demand and the growing use of AI-driven tools in clinical workflows. We will now look at how RadNet's strong revenue beat and earnings surprise could influence the existing investment narrative...

Yahoo · Oct 8, 2026

New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies

Multicenter retrospective study finds combining radiologist assessment with DeepHealth’s Prostate AI could reduce biopsies by 18.9% while identifying men with clinically significant prostate cancer with 98.4% sensitivitySOMERVILLE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced new findings published in European Radiology supporting that AI applications withi

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By